Literature DB >> 33468683

RanDeL-Seq: a High-Throughput Method to Map Viral cis- and trans-Acting Elements.

Timothy Notton1,2, Joshua J Glazier1, Victoria R Saykally1, Cassandra E Thompson1, Leor S Weinberger3,4.   

Abstract

It has long been known that noncoding genomic regions can be obligate cis elements acted upon in trans by gene products. In viruses, cis elements regulate gene expression, encapsidation, and other maturation processes, but mapping these elements relies on targeted iterative deletion or laborious prospecting for rare spontaneously occurring mutants. Here, we introduce a method to comprehensively map viral cis and trans elements at single-nucleotide resolution by high-throughput random deletion. Variable-size deletions are randomly generated by transposon integration, excision, and exonuclease chewback and then barcoded for tracking via sequencing (i.e., random deletion library sequencing [RanDeL-seq]). Using RanDeL-seq, we generated and screened >23,000 HIV-1 variants to generate a single-base resolution map of HIV-1's cis and trans elements. The resulting landscape recapitulated HIV-1's known cis-acting elements (i.e., long terminal repeat [LTR], Ψ, and Rev response element [RRE]) and, surprisingly, indicated that HIV-1's central DNA flap (i.e., central polypurine tract [cPPT] to central termination sequence [CTS]) is as critical as the LTR, Ψ, and RRE for long-term passage. Strikingly, RanDeL-seq identified a previously unreported ∼300-bp region downstream of RRE extending to splice acceptor 7 that is equally critical for sustained viral passage. RanDeL-seq was also used to construct and screen a library of >90,000 variants of Zika virus (ZIKV). Unexpectedly, RanDeL-seq indicated that ZIKV's cis-acting regions are larger than the untranscribed (UTR) termini, encompassing a large fraction of the nonstructural genes. Collectively, RanDeL-seq provides a versatile framework for generating viral deletion mutants, enabling discovery of replication mechanisms and development of novel antiviral therapeutics, particularly for emerging viral infections.IMPORTANCE Recent studies have renewed interest in developing novel antiviral therapeutics and vaccines based on defective interfering particles (DIPs)-a subset of viral deletion mutants that conditionally replicate. Identifying and engineering DIPs require that viral cis- and trans-acting elements be accurately mapped. Here, we introduce a high-throughput method (random deletion library sequencing [RanDeL-seq]) to comprehensively map cis- and trans-acting elements within a viral genome. RanDeL-seq identified essential cis elements in HIV, including the obligate nature of the once-controversial viral central polypurine tract (cPPT), and identified a new cis region proximal to the Rev responsive element (RRE). RanDeL-seq also identified regions of Zika virus required for replication and packaging. RanDeL-seq is a versatile and comprehensive technique to rapidly map cis and trans regions of a genome.
Copyright © 2021 Notton et al.

Entities:  

Keywords:  biotechnology; human immunodeficiency virus; synthetic biology

Year:  2021        PMID: 33468683      PMCID: PMC7845639          DOI: 10.1128/mBio.01724-20

Source DB:  PubMed          Journal:  mBio            Impact factor:   7.867


  92 in total

1.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

2.  Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins.

Authors:  Benjamin O Fulton; David Sachs; Shannon M Beaty; Sohui T Won; Benhur Lee; Peter Palese; Nicholas S Heaton
Journal:  Cell Rep       Date:  2015-05-21       Impact factor: 9.423

3.  Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import.

Authors:  Jeffrey D Dvorin; Peter Bell; Gerd G Maul; Masahiro Yamashita; Michael Emerman; Michael H Malim
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation.

Authors:  Mastooreh Chamanian; Katarzyna J Purzycka; Paul T Wille; Janice S Ha; David McDonald; Yong Gao; Stuart F J Le Grice; Eric J Arts
Journal:  Cell Host Microbe       Date:  2013-02-13       Impact factor: 21.023

5.  Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.

Authors:  Timo Frensing; Antje Pflugmacher; Mandy Bachmann; Britta Peschel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2014-08-19       Impact factor: 4.813

6.  Construction and applications of yellow fever virus replicons.

Authors:  Christopher T Jones; Chinmay G Patkar; Richard J Kuhn
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

7.  General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.

Authors:  Masaharu Iwasaki; Nhi Ngo; Beatrice Cubitt; John R Teijaro; Juan C de la Torre
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

8.  Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

Authors:  D F Purcell; M A Martin
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Mapping overlapping functional elements embedded within the protein-coding regions of RNA viruses.

Authors:  Andrew E Firth
Journal:  Nucleic Acids Res       Date:  2014-10-17       Impact factor: 16.971

10.  Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors.

Authors:  Jolien Vermeire; Evelien Naessens; Hanne Vanderstraeten; Alessia Landi; Veronica Iannucci; Anouk Van Nuffel; Tom Taghon; Massimo Pizzato; Bruno Verhasselt
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more
  2 in total

1.  Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance.

Authors:  Sonali Chaturvedi; Gustavo Vasen; Michael Pablo; Xinyue Chen; Nathan Beutler; Arjun Kumar; Elizabeth Tanner; Sylvia Illouz; Donna Rahgoshay; John Burnett; Leo Holguin; Pei-Yi Chen; Blaise Ndjamen; Melanie Ott; Robert Rodick; Thomas Rogers; Davey M Smith; Leor S Weinberger
Journal:  Cell       Date:  2021-11-10       Impact factor: 41.582

2.  Library-based analysis reveals segment and length dependent characteristics of defective influenza genomes.

Authors:  Marisa Mendes; Alistair B Russell
Journal:  PLoS Pathog       Date:  2021-12-09       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.